Abstract

BackgroundTransforming growth factor (TGF)-β is a multifunctional cytokine involved in cell differentiation, cell proliferation, and tissue homeostasis. Although TGF-β signaling is essential for maintaining blood vessel functions, little is known about the role of TGF-β in lymphatic homeostasis.MethodsTo delineate the role of TGF-β signaling in lymphatic vessels, TβRIIfl/fl mice were crossed with Prox1-CreERT2 mice to generate TβRIIfl/fl; Prox1-CreERT2 mice. The TβRII gene in the lymphatic endothelial cells (LECs) of the conditional knockout TβRIIiΔLEC mice was selectively deleted using tamoxifen. The effects of TβRII gene deletion on embryonic lymphangiogenesis, postnatal lymphatic structure and drainage function, tumor lymphangiogenesis, and lymphatic tumor metastasis were investigated.ResultsDeficiency of LEC-specific TGF-β signaling in embryos, where lymphangiogenesis is active, caused dorsal edema with dilated lymphatic vessels at E13.5. Postnatal mice in which lymphatic vessels had already been formed displayed dilation and increased bifurcator of lymphatic vessels after tamoxifen administration. Similar dilation was also observed in tumor lymphatic vessels. The drainage of FITC-dextran, which was subcutaneously injected into the soles of the feet of the mice, was reduced in TβRIIiΔLEC mice. Furthermore, Lewis lung carcinoma cells constitutively expressing GFP (LLC-GFP) transplanted into the footpads of the mice showed reduced patellar lymph node metastasis.ConclusionThese data suggest that TGF-β signaling in LECs maintains the structure of lymphatic vessels and lymphatic homeostasis, in addition to promoting tumor lymphatic metastasis. Therefore, suppression of TGF-β signaling in LECs might be effective in inhibiting cancer metastasis.

Highlights

  • Transforming growth factor (TGF)-β is a multifunctional cytokine involved in cell differentiation, cell proliferation, and tissue homeostasis

  • Transforming growth factor-β (TGF-β) regulates lymphatic network development In mouse development, the initiation of lymphatic vessel differentiation is observed at embryonic day 10–10.5 (E10–10.5) in the anterior cardinal vein with a subpopulation of endothelial cells expressing LYVE-1, Sox18, Prox1, and vascular endothelial growth factor receptor 3 (VEGFR3) [6] [7, 17]

  • To verify the effect of TGF-β signal deficiency on active lymphangiogenesis of Lymphatic endothelial cell (LEC), Tx was administered to pregnant mice 10.5 and 11.5 days after mating

Read more

Summary

Introduction

Transforming growth factor (TGF)-β is a multifunctional cytokine involved in cell differentiation, cell proliferation, and tissue homeostasis. TGF-β signaling is essential for maintaining blood vessel functions, little is known about the role of TGF-β in lymphatic homeostasis. The TβRII gene in the lymphatic endothelial cells (LECs) of the conditional knockout TβRIIiΔLEC mice was selectively deleted using tamoxifen. Transforming growth factor-β (TGF-β) is a secreted dimeric protein that has pleiotropic effects and plays a key role in many cellular processes during both embryogenesis and tissue homeostasis in adults [1]. The expression of the transcriptional factor Prox-1 is imperative for the development and maintenance of lymphatic endothelial cells (LECs). A master regulator of LECs, induces the expression of vascular endothelial growth factor receptor 3 (VEGFR3) in the lymphatic progenitor cells that bud from the cardinal vein. The lymphatic progenitor cells form the lymph sac in a VEGF-C/ VEGFR3 dependent manner. The molecular mechanisms that control lymphangiogenesis have been elucidated, little is known about the mechanisms that maintain the plasticity and stability of lymphatic vessels

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call